| Year |
Citation |
Score |
| 2018 |
Moncayo G, Grzmil M, Smirnova T, Zmarz P, Huber RM, Hynx D, Kohler H, Wang Y, Hotz HR, Hynes NE, Keller G, Frank S, Merlo A, Hemmings BA. SYK Inhibition Blocks Proliferation and Migration of Glioma Cells, and Modifies the Tumor Microenvironment. Neuro-Oncology. PMID 29401256 DOI: 10.1093/neuonc/noy008 |
0.426 |
|
| 2016 |
Smirnova T, Bonapace L, MacDonald G, Kondo S, Wyckoff J, Ebersbach H, Fayard B, Doelemeyer A, Coissieux MM, Heideman MR, Bentires-Alj M, Hynes NE. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages. Oncotarget. PMID 27793045 DOI: 10.18632/oncotarget.12927 |
0.5 |
|
| 2014 |
MacDonald G, Nalvarte I, Smirnova T, Vecchi M, Aceto N, Dolemeyer A, Frei A, Lienhard S, Wyckoff J, Hess D, Seebacher J, Keusch JJ, Gut H, Salaun D, Mazzarol G, et al. Memo is a copper-dependent redox protein with an essential role in migration and metastasis. Science Signaling. 7: ra56. PMID 24917593 DOI: 10.1126/scisignal.2004870 |
0.457 |
|
| 2013 |
Qian X, Hulit J, Suyama K, Eugenin EA, Belbin TJ, Loudig O, Smirnova T, Zhou ZN, Segall J, Locker J, Phillips GR, Norton L, Hazan RB. p21CIP1 mediates reciprocal switching between proliferation and invasion during metastasis. Oncogene. 32: 2292-303, 2303.e1-7. PMID 22751124 DOI: 10.1038/Onc.2012.249 |
0.734 |
|
| 2012 |
Hynes NE, Smirnova T. The 14-3-3σ tumor suppressor has multiple functions in ErbB2-induced breast cancer. Cancer Discovery. 2: 19-22. PMID 22585164 DOI: 10.1158/2159-8290.CD-11-0317 |
0.489 |
|
| 2012 |
Boimel PJ, Smirnova T, Zhou ZN, Wyckoff J, Park H, Coniglio SJ, Qian BZ, Stanley ER, Cox D, Pollard JW, Muller WJ, Condeelis J, Segall JE. Contribution of CXCL12 secretion to invasion of breast cancer cells. Breast Cancer Research : Bcr. 14: R23. PMID 22314082 DOI: 10.1186/Bcr3108 |
0.726 |
|
| 2012 |
Smirnova T, Zhou ZN, Flinn RJ, Wyckoff J, Boimel PJ, Pozzuto M, Coniglio SJ, Backer JM, Bresnick AR, Condeelis JS, Hynes NE, Segall JE. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis. Oncogene. 31: 706-15. PMID 21725367 DOI: 10.1038/Onc.2011.275 |
0.714 |
|
| 2011 |
Medina-Ramirez CM, Goswami S, Smirnova T, Bamira D, Benson B, Ferrick N, Segall J, Pollard JW, Kitsis RN. Apoptosis inhibitor ARC promotes breast tumorigenesis, metastasis, and chemoresistance. Cancer Research. 71: 7705-15. PMID 22037876 DOI: 10.1158/0008-5472.Can-11-2192 |
0.731 |
|
| 2011 |
Smirnova T, Adomako A, Locker J, Van Rooijen N, Prystowsky MB, Segall JE. In vivo invasion of head and neck squamous cell carcinoma cells does not require macrophages. The American Journal of Pathology. 178: 2857-65. PMID 21641405 DOI: 10.1016/J.Ajpath.2011.02.030 |
0.725 |
|
| 2011 |
Medina-Ramirez CM, Gowasmi S, Smirnova T, Bamira D, Condeelis J, Segall J, Pollard JW, Kitsis RN. Abstract 4695: Apoptosis inhibitor ARC as a novel mediator of breast tumorigenesis, metastasis and chemoresistance Cancer Research. 71: 4695-4695. DOI: 10.1158/1538-7445.Am2011-4695 |
0.712 |
|
| 2010 |
Smirnova T, Wyckoff J, Segall JE. Abstract 3395: Role of ErbB3 signaling in tumor cell motility and metastasis Cancer Research. 70: 3395-3395. DOI: 10.1158/1538-7445.Am10-3395 |
0.772 |
|
| 2009 |
Hernandez L, Smirnova T, Wyckoff J, Condeelis J, Segall JE. In vivo assay for tumor cell invasion. Methods in Molecular Biology (Clifton, N.J.). 571: 227-38. PMID 19763970 DOI: 10.1007/978-1-60761-198-1_15 |
0.727 |
|
| 2009 |
Hernandez L, Smirnova T, Kedrin D, Wyckoff J, Zhu L, Stanley ER, Cox D, Muller WJ, Pollard JW, Van Rooijen N, Segall JE. The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12. Cancer Research. 69: 3221-7. PMID 19293185 DOI: 10.1158/0008-5472.Can-08-2871 |
0.728 |
|
| 2007 |
Smirnova T, Segall JE. Amoeboid chemotaxis: future challenges and opportunities. Cell Adhesion & Migration. 1: 165-70. PMID 19262145 DOI: 10.4161/Cam.1.4.5305 |
0.592 |
|
| Show low-probability matches. |